Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016

被引：13

作者：

Posthuma, Hidde L. A. ^{[1
]}

Zijlstra, Josee M. ^{[1
]}

Visser, Otto ^{[2
]}

Lugtenburg, Pieternella J. ^{[3
]}

Kersten, Marie Jose ^{[4
,5
]}

Dinmohamed, Avinash G. ^{[1
,4
,6
,7
]}

机构：

[1] Vrije Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Dept Haematol, Amsterdam, Netherlands

[2] Netherlands Comprehens Canc Org IKNL Utrecht, Dept Registrat, Utrecht, Netherlands

[3] Erasmus MC Canc Inst, Dept Haematol, Rotterdam, Netherlands

[4] Univ Amsterdam, Amsterdam UMC, Canc Ctr Amsterdam, Dept Haematol, Amsterdam, Netherlands

[5] Lymphoma & Myeloma Ctr Amsterdam LYMMCARE, Amsterdam, Netherlands

[6] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands

[7] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 01期

关键词：

nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL); cancer epidemiology; population-based registry; incidence; survival;

D O I：

10.1111/bjh.16290

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this nationwide, population-based study, we assessed trends in primary treatment and survival among 687 patients with nodular lymphocyte-predominant Hodgkin lymphoma (75% males; median age, 40 years; and 74% stage-I/II disease) diagnosed in the Netherlands between 1993-2016. There were no noteworthy changes in the application of primary therapy over time among adult patients across the different disease stages and age groups. Survival among various subgroups of adult patients was largely comparable to the expected survival of the general population. A particularly encouraging finding was that young adult patients experienced virtually no excess mortality, as compared to the general population.

引用

页码：117 / 121

页数：5

共 50 条

[31] Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma
Farhan, Roiya
Alqarni, Nof S.
Algiraigri, Ali H.
JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2020, 15 (06): : 554 - 556
[32] Excellent Long-term Outcomes in Patients With Early Stage Nodular Lymphocyte-Predominant Hodgkin Lymphoma Treated With Radiation Therapy
Solanki, A. A.
LeMieux, M. H.
Mahmood, U.
Hasan, Y.
Koshy, M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S60 - S61
[33] Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
Davidl, James A.
Huang, James Z.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 145 (01) : 107 - 115
[34] Diagnostic Utility of Flow Cytometry Analysis of Reactive T-Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
David, J. A.
Huang, J. Z.
MODERN PATHOLOGY, 2014, 27 : 344A - 344A
[35] Diagnostic Utility of Flow Cytometry Analysis of Reactive T-Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma
David, J. A.
Huang, J. Z.
LABORATORY INVESTIGATION, 2014, 94 : 344A - 344A
[36] Treatment of Stage IA Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): An Analysis from the German Hodgkin Study Group (GHSG)
Eichenauer, Dennis A.
Pluetschow, Annette
Fuchs, Michael
Behringer, Karolin
Boell, Boris
von Tresckow, Bastian
Diehl, Volker
Borchmann, Peter
Engert, Andreas
BLOOD, 2014, 124 (21)
[37] Nodular lymphocyte-predominant Hodgkin lymphoma of the tonsil: A case study using immunohistochemistry and FISH analysis and review of the literature
Ioannou M.G.
Kouvaras E.
Gletsou E.
Papacharalambous C.
Matsouka P.
Koukoulis G.K.
van der Walt J.D.
Journal of Hematopathology, 2011, 4 (4) : 227 - 231
[38] Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma
Pinnix, Chelsea C.
Milgrom, Sarah A.
Cheah, Chan Yoon
Gunther, Jillian R.
Ludmir, Ethan B.
Wogan, Christine F.
Nastoupil, Loretta J.
Neelapu, Sattva S.
Westin, Jason
Lee, Hun J.
Iyer, Swaminathan P.
Steiner, Raphael E.
Fayad, Luis E.
Fowler, Nathan H.
Wang, Michael L.
Samaniego, Felipe
Rodriguez, Maria A.
Rich, Amy E.
Medeiros, L. Jeffrey
Dabaja, Bouthaina S.
BLOOD ADVANCES, 2019, 3 (09) : 1356 - 1367
[39] PET-2-guided escalated BEACOPP for patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group
Eichenauer, D. A.
Kreissl, S.
Buehnen, I.
Goergen, H.
Hartmann, S.
Fuchs, M.
von Tresckow, B.
Engert, A.
Borchmann, P.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 87 - 88
[40] Long-Term Outcomes in Patients with Early Stage Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Treated with Radiotherapy
Solanki, Abhishek A.
LeMieux, Melissa Horoschak
Chiu, Brian C. -H.
Mahmood, Usama
Hasan, Yasmin
Koshy, Matthew
PLOS ONE, 2013, 8 (09):

← 1 2 3 4 5 →